Effective from
- Added
Long term (current) use of immunosuppressant
Category — select a more specific code
CDC/NCHS · FY2023any therapeutic drug level monitoring (Z51.81)
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2022-10-01
Latest recorded change · FY2023
Effective from
Long term (current) use of immunosuppressant
Category — select a more specific code
CDC/NCHS · FY2023| All editions | Effective from | Code history |
|---|---|---|
| FY2023 | 2022-10-01 | Added |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
The official Tabular List has no additional instructions at this code level.
Review the instructions inherited from its parent categories below. Inherited instructions ↓
long term (current) drug use for prophylactic purposes
any therapeutic drug level monitoring (Z51.81)
Z79.620Long term (current) use of immunosuppressive biologicBillable / specificZ79.621Long term (current) use of calcineurin inhibitorBillable / specificZ79.622Long term (current) use of Janus kinase inhibitorBillable / specificZ79.623Long term (current) use of mammalian target of rapamycin (mTOR) inhibitorBillable / specificZ79.624Long term (current) use of inhibitors of nucleotide synthesisBillable / specificOther entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| Z79.60 | Long term (current) use of unspecified immunomodulators and immunosuppressants | Billable / specific |
| Z79.61 | Long term (current) use of immunomodulator | Billable / specific |
| Z79.63 | Long term (current) use of chemotherapeutic agent | Category · further specificity required |
| Z79.64 | Long term (current) use of myelosuppressive agent | Billable / specific |
| Z79.69 | Long term (current) use of other immunomodulators and immunosuppressants | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗